Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib with Irinotecan and Cisplatin in Esophageal Cancer
NCT00183807Phase 2Terminated
- Sponsor
- University of Southern California
- Start
- Oct 2003
- Primary completion
- Feb 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of celecoxib in esophageal cancer, sponsored by University of Southern California. Primary endpoint: Time to Progression. Started Oct 2003; status: terminated.
02
Drugs
celecoxib
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00183807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00183807.